These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 34964855)

  • 1. Comparison of Response to Definitive Radiotherapy for Localized Prostate Cancer in Black and White Men: A Meta-analysis.
    Ma TM; Romero T; Nickols NG; Rettig MB; Garraway IP; Roach M; Michalski JM; Pisansky TM; Lee WR; Jones CU; Rosenthal SA; Wang C; Hartman H; Nguyen PL; Feng FY; Boutros PC; Saigal C; Chamie K; Jackson WC; Morgan TM; Mehra R; Salami SS; Vince R; Schaeffer EM; Mahal BA; Dess RT; Steinberg ML; Elashoff D; Sandler HM; Spratt DE; Kishan AU
    JAMA Netw Open; 2021 Dec; 4(12):e2139769. PubMed ID: 34964855
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Androgen Deprivation Therapy and Outcomes After Radiation Therapy in Black Patients With Prostate Cancer.
    Morgan KM; Riviere P; Nelson TJ; Guram K; Deshler LN; Sabater Minarim D; Duran EA; Banegas MP; Rose BS
    JAMA Netw Open; 2024 Jun; 7(6):e2415911. PubMed ID: 38857047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of Black Race With Prostate Cancer-Specific and Other-Cause Mortality.
    Dess RT; Hartman HE; Mahal BA; Soni PD; Jackson WC; Cooperberg MR; Amling CL; Aronson WJ; Kane CJ; Terris MK; Zumsteg ZS; Butler S; Osborne JR; Morgan TM; Mehra R; Salami SS; Kishan AU; Wang C; Schaeffer EM; Roach M; Pisansky TM; Shipley WU; Freedland SJ; Sandler HM; Halabi S; Feng FY; Dignam JJ; Nguyen PL; Schipper MJ; Spratt DE
    JAMA Oncol; 2019 Jul; 5(7):975-983. PubMed ID: 31120534
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of Social Determinants of Health and Prostate Cancer Outcomes Among Black and White Patients: A Systematic Review and Meta-analysis.
    Vince RA; Jiang R; Bank M; Quarles J; Patel M; Sun Y; Hartman H; Zaorsky NG; Jia A; Shoag J; Dess RT; Mahal BA; Stensland K; Eyrich NW; Seymore M; Takele R; Morgan TM; Schipper M; Spratt DE
    JAMA Netw Open; 2023 Jan; 6(1):e2250416. PubMed ID: 36630135
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of a Biopsy-Based Genomic Classifier in High-Risk Prostate Cancer: Meta-Analysis of the NRG Oncology/Radiation Therapy Oncology Group 9202, 9413, and 9902 Phase 3 Randomized Trials.
    Nguyen PL; Huang HR; Spratt DE; Davicioni E; Sandler HM; Shipley WU; Efstathiou JA; Simko JP; Pollack A; Dicker AP; Roach M; Rosenthal SA; Zeitzer KL; Mendez LC; Hartford AC; Hall WA; Desai AB; Rabinovitch RA; Peters CA; Rodgers JP; Tran P; Feng FY
    Int J Radiat Oncol Biol Phys; 2023 Jul; 116(3):521-529. PubMed ID: 36596347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association Between Prostate-Specific Antigen Screening and Prostate Cancer Mortality Among Non-Hispanic Black and Non-Hispanic White US Veterans.
    Sherer MV; Qiao EM; Kotha NV; Qian AS; Rose BS
    JAMA Oncol; 2022 Oct; 8(10):1471-1476. PubMed ID: 35925581
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of Biochemical Failure After Salvage Radiation Therapy on Prostate Cancer-specific Mortality: Competition Between Age and Time to Biochemical Failure.
    Jackson WC; Suresh K; Tumati V; Dess RT; Soni PD; Zhao SG; Zumsteg ZS; Hannan R; Hollenbeck BK; George A; Kaffenberger SD; Salami SS; Hearn JWD; Morgan TM; Mehra R; Schipper M; Feng FY; Desai NB; Spratt DE
    Eur Urol Oncol; 2018 Sep; 1(4):276-282. PubMed ID: 31100248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sequencing of Androgen-Deprivation Therapy of Short Duration With Radiotherapy for Nonmetastatic Prostate Cancer (SANDSTORM): A Pooled Analysis of 12 Randomized Trials.
    Ma TM; Sun Y; Malone S; Roach M; Dearnaley D; Pisansky TM; Feng FY; Sandler HM; Efstathiou JA; Syndikus I; Hall EC; Tree AC; Sydes MR; Cruickshank C; Roy S; Bolla M; Maingon P; De Reijke T; Nabid A; Carrier N; Souhami L; Zapatero A; Guerrero A; Alvarez A; Gonzalez San-Segundo C; Maldonado X; Romero T; Steinberg ML; Valle LF; Rettig MB; Nickols NG; Shoag JE; Reiter RE; Zaorsky NG; Jia AY; Garcia JA; Spratt DE; Kishan AU;
    J Clin Oncol; 2023 Feb; 41(4):881-892. PubMed ID: 36269935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Race and risk of metastases and survival after radical prostatectomy: Results from the SEARCH database.
    Freedland SJ; Vidal AC; Howard LE; Terris MK; Cooperberg MR; Amling CL; Kane CJ; Aronson WJ;
    Cancer; 2017 Nov; 123(21):4199-4206. PubMed ID: 28654204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Racial and Ethnic Disparities in Prostate Cancer Outcomes in the Veterans Affairs Health Care System.
    Yamoah K; Lee KM; Awasthi S; Alba PR; Perez C; Anglin-Foote TR; Robison B; Gao A; DuVall SL; Katsoulakis E; Wong YN; Markt SC; Rose BS; Burri R; Wang C; Aboiralor O; Fink AK; Nickols NG; Lynch JA; Garraway IP
    JAMA Netw Open; 2022 Jan; 5(1):e2144027. PubMed ID: 35040965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Racial differences in the treatment and outcomes for prostate cancer in Massachusetts.
    Cole AP; Herzog P; Iyer HS; Marchese M; Mahal BA; Lipsitz SR; Nyambose J; Gershman ST; Kennedy M; Merriam G; Rebbeck TR; Trinh QD
    Cancer; 2021 Aug; 127(15):2714-2723. PubMed ID: 33999405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of type of definitive treatment on race-based differences in prostate cancer-specific survival.
    Frego N; Labban M; Stone BV; Koelker M; Alkhatib K; Lughezzani G; Buffi NM; Lipsitz SR; Weissman JS; Fletcher SA; Kibel AS; Trinh QD; Cole AP
    Prostate; 2023 Aug; 83(11):1099-1111. PubMed ID: 37150867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Short-term androgen suppression and radiotherapy versus intermediate-term androgen suppression and radiotherapy, with or without zoledronic acid, in men with locally advanced prostate cancer (TROG 03.04 RADAR): 10-year results from a randomised, phase 3, factorial trial.
    Denham JW; Joseph D; Lamb DS; Spry NA; Duchesne G; Matthews J; Atkinson C; Tai KH; Christie D; Kenny L; Turner S; Gogna NK; Diamond T; Delahunt B; Oldmeadow C; Attia J; Steigler A
    Lancet Oncol; 2019 Feb; 20(2):267-281. PubMed ID: 30579763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcomes of Black men with prostate cancer treated with radiation therapy in the Veterans Health Administration.
    McKay RR; Sarkar RR; Kumar A; Einck JP; Garraway IP; Lynch JA; Mundt AJ; Murphy JD; Stewart TF; Yamoah K; Rose BS
    Cancer; 2021 Feb; 127(3):403-411. PubMed ID: 33036065
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Race and survival of men treated for prostate cancer on radiation therapy oncology group phase III randomized trials.
    Roach M; Lu J; Pilepich MV; Asbell SO; Mohiuddin M; Grignon D
    J Urol; 2003 Jan; 169(1):245-50. PubMed ID: 12478146
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiation therapy dose and androgen deprivation therapy in localized prostate cancer: a meta-regression of 5-year outcomes in phase III randomized controlled trials.
    Jiang T; Markovic D; Patel J; Juarez JE; Ma TM; Shabsovich D; Nickols NG; Reiter RE; Elashoff D; Rettig MB; Zaorsky NG; Spratt DE; Kishan AU
    Prostate Cancer Prostatic Dis; 2022 Mar; 25(1):126-128. PubMed ID: 34400799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Local Failure and Survival After Definitive Radiotherapy for Aggressive Prostate Cancer: An Individual Patient-level Meta-analysis of Six Randomized Trials.
    Kishan AU; Chu FI; King CR; Seiferheld W; Spratt DE; Tran P; Wang X; Pugh SE; Sandler KA; Bolla M; Maingon P; De Reijke T; Nickols NG; Rettig M; Drakaki A; Liu ST; Reiter RE; Chang AJ; Feng FY; Sajed D; Nguyen PL; Kupelian PA; Steinberg ML; Boutros PC; Elashoff D; Collette L; Sandler HM
    Eur Urol; 2020 Feb; 77(2):201-208. PubMed ID: 31718822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined Androgen Blockade in Localized Prostate Cancer Treated With Definitive Radiation Therapy.
    Vitzthum LK; Straka C; Sarkar RR; McKay R; Randall JM; Sandhu A; Murphy JD; Rose BS
    J Natl Compr Canc Netw; 2019 Dec; 17(12):1497-1504. PubMed ID: 31805534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The need for androgen deprivation therapy in patients with intermediate-risk prostate cancer treated with dose-escalated external beam radiation therapy.
    Dong Y; Ruth KJ; Churilla TM; Viterbo R; Sobczak ML; Smaldone MC; Chen DY; Uzzo RG; Hallman MH; Horwitz EM
    Can J Urol; 2017 Feb; 24(1):8656-8662. PubMed ID: 28263132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.